Literature DB >> 26783030

Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans.

Chengjie Shu1,2, Lingmei Sun3, Weiming Zhang4,5.   

Abstract

The Caenorhabditis elegans model can be used to study Candida albicans virulence and host immunity, as well as to identify plant-derived natural products to use against C. albicans. Thymol is a hydrophobic phenol compound from the aromatic plant thyme. In this study, the in vitro data demonstrated concentration-dependent thymol inhibition of both C. albicans growth and biofilm formation during different developmental phases. With the aid of the C. elegans system, we performed in vivo assays, and our results further showed the ability of thymol to increase C. elegans life span during infection, inhibit C. albicans colony formation in the C. elegans intestine, and increase the expression levels of host antimicrobial genes. Moreover, among the genes that encode the p38 MAPK signaling pathway, mutation of the pmk-1 or sek-1 gene decreased the beneficial effects of thymol's antifungal activity against C. albicans and thymol's maintenance of the innate immune response in nematodes. Western blot data showed the level of phosphorylation of pmk-1 was dramatically decreased against C. albicans. In nematodes, treatment with thymol recovered the dysregulation of pmk-1 and sek-1 gene expressions, the phosphorylation level of PMK-1 caused by C. albicans infection. Therefore, thymol may act, at least in part, through the function of the p38 MAPK signaling pathway to protect against C. albicans infection and maintain the host innate immune response to C. albicans. Our results indicate that the p38 MAPK signaling pathway plays a crucial role in regulating the beneficial effects observed after nematodes infected with C. albicans were treated with thymol.

Entities:  

Keywords:  Caenorhabditis elegans; Candida albicans; Immunity; Thymol

Mesh:

Substances:

Year:  2016        PMID: 26783030     DOI: 10.1007/s12026-016-8785-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  34 in total

1.  Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.

Authors:  L-M Sun; K Liao; S Liang; P-H Yu; D-Y Wang
Journal:  J Appl Microbiol       Date:  2015-02-03       Impact factor: 3.772

2.  Association of oxidative stress with the formation of reproductive toxicity from mercury exposure on hermaphrodite nematode Caenorhabditis elegans.

Authors:  Qiuli Wu; Kewen He; Peidang Liu; Yinxia Li; Dayong Wang
Journal:  Environ Toxicol Pharmacol       Date:  2011-05-05       Impact factor: 4.860

3.  Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs.

Authors:  Bryan Larsen; Seth Anderson; Andrea Brockman; Michael Essmann; Martin Schmidt
Journal:  Yeast       Date:  2006-08       Impact factor: 3.239

4.  The genetics of Caenorhabditis elegans.

Authors:  S Brenner
Journal:  Genetics       Date:  1974-05       Impact factor: 4.562

5.  Pre-treatment with mild UV irradiation suppresses reproductive toxicity induced by subsequent cadmium exposure in nematodes.

Authors:  Dayong Wang; Xiaojuan Xing
Journal:  Ecotoxicol Environ Saf       Date:  2009-12-31       Impact factor: 6.291

6.  Thymol inhibits Candida albicans biofilm formation and mature biofilm.

Authors:  Pier Carlo Braga; Maria Culici; Marina Alfieri; Monica Dal Sasso
Journal:  Int J Antimicrob Agents       Date:  2008-03-10       Impact factor: 5.283

7.  Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses.

Authors:  Read Pukkila-Worley; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

8.  Cranberry extract standardized for proanthocyanidins promotes the immune response of Caenorhabditis elegans to Vibrio cholerae through the p38 MAPK pathway and HSF-1.

Authors:  Jessica Dinh; Joseph T Angeloni; Daniel B Pederson; Xiaoxia Wang; Min Cao; Yuqing Dong
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

Review 9.  Candida albicans pathogenicity mechanisms.

Authors:  François L Mayer; Duncan Wilson; Bernhard Hube
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

10.  Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay.

Authors:  Ikechukwu Okoli; Jeffrey J Coleman; Emmanouil Tampakakis; Emmanouil Tempakakis; W Frank An; Edward Holson; Florence Wagner; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Andy Stern; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more
  11 in total

Review 1.  Caenorhabditis elegans as a model animal for investigating fungal pathogenesis.

Authors:  Moses Madende; Jacobus Albertyn; Olihile Sebolai; Carolina H Pohl
Journal:  Med Microbiol Immunol       Date:  2019-09-25       Impact factor: 3.402

2.  Molecular Mechanisms for Anti-aging of Low-Vacuum Cold Plasma Pretreatment in Caenorhabditis elegans.

Authors:  Jiamei Tian; Yumeng Tang; Linsong Yang; Jie Ren; Qing Qing; Yuheng Tao; Jieting Xu; Jie Zhu
Journal:  Appl Biochem Biotechnol       Date:  2022-06-06       Impact factor: 3.094

Review 3.  An Update on Candida tropicalis Based on Basic and Clinical Approaches.

Authors:  Diana L Zuza-Alves; Walicyranison P Silva-Rocha; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2017-10-13       Impact factor: 5.640

4.  The clinical evaluation of Vi-one chlorhexidine mouthwash on plaque-induced gingivitis: A double-blind randomized clinical trial.

Authors:  Babak Amoian; Marzyeh Omidbakhsh; Soraya Khafri
Journal:  Electron Physician       Date:  2017-09-25

Review 5.  Antifungal Compounds against Candida Infections from Traditional Chinese Medicine.

Authors:  Xin Liu; Zhiming Ma; Jingxiao Zhang; Longfei Yang
Journal:  Biomed Res Int       Date:  2017-12-28       Impact factor: 3.411

Review 6.  Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Authors:  Patrick Van Dijck; Jelmer Sjollema; Bruno P Cammue; Katrien Lagrou; Judith Berman; Christophe d'Enfert; David R Andes; Maiken C Arendrup; Axel A Brakhage; Richard Calderone; Emilia Cantón; Tom Coenye; Paul Cos; Leah E Cowen; Mira Edgerton; Ana Espinel-Ingroff; Scott G Filler; Mahmoud Ghannoum; Neil A R Gow; Hubertus Haas; Mary Ann Jabra-Rizk; Elizabeth M Johnson; Shawn R Lockhart; Jose L Lopez-Ribot; Johan Maertens; Carol A Munro; Jeniel E Nett; Clarissa J Nobile; Michael A Pfaller; Gordon Ramage; Dominique Sanglard; Maurizio Sanguinetti; Isabel Spriet; Paul E Verweij; Adilia Warris; Joost Wauters; Michael R Yeaman; Sebastian A J Zaat; Karin Thevissen
Journal:  Microb Cell       Date:  2018-06-14

Review 7.  Natural Compounds: A Hopeful Promise as an Antibiofilm Agent Against Candida Species.

Authors:  Aref Shariati; Mojtaba Didehdar; Shabnam Razavi; Mohsen Heidary; Fatemeh Soroush; Zahra Chegini
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

8.  2E,4E-Decadienoic Acid, a Novel Anti-Oomycete Agent from Coculture of Bacillus subtilis and Trichoderma asperellum.

Authors:  Xi-Fen Zhang; Qing-Yu Li; Mei Wang; Si-Qi Ma; Yan-Fen Zheng; Yi-Qiang Li; Dong-Lin Zhao; Cheng-Sheng Zhang
Journal:  Microbiol Spectr       Date:  2022-08-09

9.  A systematic review on ethnopharmacology, phytochemistry and pharmacological aspects of Thymus vulgaris Linn.

Authors:  Shashank M Patil; Ramith Ramu; Prithvi S Shirahatti; Chandan Shivamallu; Raghavendra G Amachawadi
Journal:  Heliyon       Date:  2021-05-18

Review 10.  Plant Preparations and Compounds with Activities against Biofilms Formed by Candida spp.

Authors:  Tomasz M Karpiński; Marcin Ożarowski; Agnieszka Seremak-Mrozikiewicz; Hubert Wolski; Artur Adamczak
Journal:  J Fungi (Basel)       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.